# The Oncology Institute Inc. (TOI)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $455M  
**Price:** $4.93 (+5.34%)

> The Oncology Institute, Inc. is a value-based community oncology group providing comprehensive cancer care treatment services across multiple settings. Operating through three primary segments—Dispensary, Patient Care, and Clinical Trials and Other—the company delivers specialized oncology services including infusion centers, in-house pharmaceutical dispensary, outpatient blood transfusions, outpatient stem cell transplants, financial counseling, clinical trials, comprehensive laboratory testing, and end-of-life counseling. With over 100 employed clinicians and more than 800 team members operating across numerous clinic locations, The Oncology Institute serves a large patient population with evidence-based, high-quality cancer care. Founded in 2007 and headquartered in Cerritos, California, the company focuses on advancing oncology through value-based care models designed to improve patient outcomes while optimizing healthcare delivery in community settings rather than traditional hospital environments.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $503M | — | -$36M | -$61M | $-0.54 |
| 2024 | $393M | — | -$60M | -$65M | $-0.71 |
| 2023 | $324M | — | -$77M | -$83M | $-0.92 |
| 2022 | $252M | — | -$82M | $152,000 | $-0.21 |
| 2021 | $203M | — | -$46M | -$11M | $-0.16 |
| 2020 | $188M | — | -$8M | -$14M | $-0.24 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $165M | $180M | -$16M | — | $77M |
| 2024 | $173M | $169M | $4M | — | $93M |
| 2023 | $209M | $152M | $57M | — | $87M |
| 2022 | $262M | $138M | $123M | — | $81M |
| 2021 | $203M | $99M | $104M | — | — |
| 2020 | $66M | $38M | $28M | $900,000 | $7M |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$25M | $3M | -$28M |
| 2024 | -$27M | $4M | -$30M |
| 2023 | -$36M | $5M | -$41M |
| 2022 | -$62M | $6M | -$67M |
| 2021 | -$33M | $3M | -$36M |
| 2020 | $508,000 | $1M | -$686,000 |

Source: [CompaniesByCap](https://companiesbycap.com/company/TOI)